126 related articles for article (PubMed ID: 1724099)
1. [Effect of hydroxyethyl starch and dextran on metabolism of extremity muscles in patients with arterial occlusive disease].
Stark G; Tischler R; Decrinis M; Lafer M; Obernosterer A; Pieber D; Pilger E
Vasa Suppl; 1991; 33():171. PubMed ID: 1724099
[No Abstract] [Full Text] [Related]
2. [Hemodilution in peripheral arterial occlusive disease. Placebo controlled randomized double-blind study with hydroxyethyl starch or dextran].
Ernst E; Kollar L; Matrai A
Acta Med Austriaca; 1991; 18 Suppl 1():27-9. PubMed ID: 1719730
[TBL] [Abstract][Full Text] [Related]
3. [Effect of a 10% and 6% hydroxyethyl starch solution (molecular weight 200,000/0.62) in comparison with a 10% dextran solution (molecular weight 40,000) on flow properties of blood and tissue oxygen pressure in patients with intermittent claudication].
Ehrly AM; Seebens H; Saeger-Lorenz K
Infusionstherapie; 1988 Oct; 15(5):181-7. PubMed ID: 2461906
[TBL] [Abstract][Full Text] [Related]
4. [Hemorheologic effects of hydroxyethyl starch 200/0.5, dextran 40, oxypolygelatine and full electrolyte solution over 48 hours].
Brehme S; Keysser G; Turowski A; Schmidt HH
Z Gesamte Inn Med; 1993 Oct; 48(10):506-10. PubMed ID: 7504854
[TBL] [Abstract][Full Text] [Related]
5. [Hemorheologic and clinical in vitro and in vivo studies of the effectiveness of isovolemic hemodilution using Gelafusal and Infukoll M40 in patients with peripheral arterial occlusive disease].
Pöhlmann G; Braumann A; Grohmann G
Vasa Suppl; 1991; 32():342-4. PubMed ID: 1722914
[No Abstract] [Full Text] [Related]
6. [Metabolic effects of intermittent exercise by patients with stage II arterial occlusive disease].
Maass U; Goller B; Grote R
Vasa; 1995; 24(2):141-7. PubMed ID: 7793146
[TBL] [Abstract][Full Text] [Related]
7. [Effects of a nucleotide-nucleoside mixture on ischemic muscle metabolism in patients with stage II peripheral arterial occlusive disease. MR spectroscopic and biochemical analytic results].
Rexroth W; Huber KH; Rädle J; Semmler W; van Kaick G
Vasa; 1994; 23(2):98-108. PubMed ID: 8036845
[TBL] [Abstract][Full Text] [Related]
8. [Hemodilution in patients with stage IIb peripheral arterial occlusive disease: prospective randomized double-blind comparison of middle-molecular weight hydroxyethyl starch and low-molecular weight dextran solution].
Kiesewetter H; Jung F; Blume J; Gerhards M
Klin Wochenschr; 1987 Apr; 65(7):324-30. PubMed ID: 2438451
[TBL] [Abstract][Full Text] [Related]
9. [Studies of muscle metabolism in chronic major limb arterial occlusive disease patients by unilateral ergometric lower leg stress (III)].
Nissen P; Alexander K
Vasa; 1985; 14(4):330-5. PubMed ID: 4072367
[No Abstract] [Full Text] [Related]
10. Effects of different oxygen concentrations during hemodilution with Fluosol or LMW-Dextran in rabbits.
Beisbarth H; Madjidi A; Frey R
Prog Clin Biol Res; 1983; 122():373-80. PubMed ID: 6192450
[No Abstract] [Full Text] [Related]
11. [Hemorheologic changes in preoperative hemodilution during total hip replacement. Randomized study comparing hydroxyethyl starch 200,000/0.62 (HES) and a dextran 60,000].
Lartigue B; Barre J; Nguyen P; Potron G
J Mal Vasc; 1994; 19(1):27-31. PubMed ID: 7517991
[TBL] [Abstract][Full Text] [Related]
12. [Effect of low and high molecular weight dextrans on selected serum lipid parameters. 1].
Rühlmann C; Koksch M; Kuklinski B
Z Gesamte Inn Med; 1992 Jan; 47(1):6-11. PubMed ID: 1373926
[TBL] [Abstract][Full Text] [Related]
13. [Iso- and hypervolemic hemodilution with hydroxyethyl starch (HES 200/.05 10%) in patients with II b peripheral arterial occlusive disease].
Kiesewetter H; Blume J; Jung F; Spitzer S; Gerhards M; Waldhausen P; Wenzel E
Wien Med Wochenschr; 1989 Sep; 139(17):396-401. PubMed ID: 2480029
[TBL] [Abstract][Full Text] [Related]
14. [Exertion-induced metabolic changes in arterial occlusive diseases with obstruction at different levels].
Maass U; Grote R; Alexander K
Vasa; 1986; 15(3):212-6. PubMed ID: 3094266
[No Abstract] [Full Text] [Related]
15. [Muscle metabolism and blood circulation under ergometric stress in arterial occlusive disease (II)].
Nissen P; Maas U; Hundeshagen H; Alexander K
Vasa; 1985; 14(1):31-4. PubMed ID: 3976274
[No Abstract] [Full Text] [Related]
16. [Effects of prostaglandin El on hemodynamics and metabolism of the extremities in healthy humans and patients with stage III and IV arterial occlusive disease].
Rexroth W; Amendt K; Römmele U; Stein U; Wagner E; Hild R
Vasa; 1985; 14(3):220-4. PubMed ID: 4050061
[No Abstract] [Full Text] [Related]
17. [Hemodilution therapy of acute inner ear damage].
Pilgramm M
Acta Med Austriaca; 1991; 18 Suppl 1():60-2. PubMed ID: 1719734
[TBL] [Abstract][Full Text] [Related]
18. [Considerations in hemodilution therapy of stroke].
Oder W; Kollegger H; Zeiler K; Deecke L
Acta Med Austriaca; 1989; 16(5):109-14. PubMed ID: 2483488
[TBL] [Abstract][Full Text] [Related]
19. [Adaptation of peripheral circulation to isolated calf muscle stress and its relation to blood gases and substrate concentrations in femoral and popliteal venous blood in patients with occlusive disease].
Maass U; Fröhlich H; Konrad H; Alexander K
Vasa; 1987; 16(3):256-61. PubMed ID: 3660935
[No Abstract] [Full Text] [Related]
20. [Treatment of apoplexy with hypervolemic hemodilution].
Kabus C; Semler P
Z Arztl Fortbild (Jena); 1992 Dec; 86(23-24):1153-60. PubMed ID: 1283649
[No Abstract] [Full Text] [Related]
[Next] [New Search]
